Peptides - Retatrutide | |
Retatrutide (LY-3437943) is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist (GLP-1, Global Investment Program, and GCGR receptor) ![]() | |
Target Nation: Northern Ireland Target City : All Cities Last Update : 23 June 2025 8:47 AM Number of Views: 22 | Item Owner : jennie Contact Email: Contact Phone: +85265295284 |
Friendly reminder: Click here to read some tips. |